Mc Kinley Carter Wealth Services, Inc. Medicenna Therapeutics Corp. Transaction History

Mc Kinley Carter Wealth Services, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	BUY	$1.26 - $1.92 $83,997 - $127,996	66,665 Added 529.34%	79,259 $101,000
Q4 2021 Feb 07, 2022	SELL	$1.53 - $2.85 $30,053 - $55,982	-19,643 Reduced 60.93%	12,594 $21,000
Q2 2021 Aug 12, 2021	BUY	$2.97 - $4.28 $21,214 - $30,572	7,143 Added 28.46%	32,237 $97,000
Q4 2020 Feb 12, 2021	BUY	$3.7 - $5.97 $92,847 - $149,811	25,094 New	25,094 $117,000

863K

Ticker MDNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,637,504
Market Cap $21.6M
Description
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...

Get notified when there are updates to the investment portfolio of Mc Kinley Carter Wealth Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Mc Kinley Carter Wealth Services, Inc. with notifications on news.